You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

renal carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1

Recruiting
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital Zhejiang University School of Med
    Mar 27, 2023

    Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) Trial run by the National Cancer Institute

    Not yet recruiting
    • Advanced Clear Cell Renal Carcinoma (Ccrcc)
    • Papillary Renal Cell Carcinoma (Prcc)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Cadonilimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant Therapy Trial in Guangzhou (Cadonilimab Combined With Lenvatinib)

    Recruiting
    • Cadonilimab
    • +2 more
    • Cadonilimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 16, 2023

    Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

    Recruiting
    • Metastatic Clear Cell Renal Carcinoma
    • CT scan
    • Plasma collection
    • Milan, Mi, Italy
      Istituto Tumori
    Mar 13, 2023

    Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)

    Terminated
    Has Results
    • Clear-Cell Renal Carcinoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 27, 2022

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Moesin Expression in Clear Cell Renal Cell Carcinoma

      Completed
      • Renal Cell Carcinoma
      • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
      • (no location specified)
      Sep 20, 2023

      ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

      Not yet recruiting
      • ccRCC
      • +20 more
      • (no location specified)
      Jul 6, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 28, 2023

      Renal Cell Carcinoma Trial (Sunitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 11, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

      Available
      • Clear Cell Renal Cell Carcinoma
      • 89Zr-DFO-girentuximab
      • Los Angeles, California
        UCLA
      Oct 12, 2023

      Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • ST-1898 tablets
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      Nov 6, 2023

      Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • (no location specified)
      May 14, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023

      Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pembrolizumab injection
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 20, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Clinical Factors on Prognosis of Papillary Renal Cell Carcinoma

      Completed
      • Carcinoma, Renal Cell
      • We do not have any interventions. This study is based on obseravation.
      • (no location specified)
      Oct 27, 2023

      Renal Cell Carcinoma Trial (HS-10516)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 24, 2023

      Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Computed Tomography, Magnetic Resonance Imaging,

      Not yet recruiting
      • Metastatic Renal Cell Carcinoma
      • Stage IV Renal Cell Cancer AJCC v8
      • Computed Tomography
      • +4 more
      • (no location specified)
      May 8, 2023

      Renal Cell Carcinoma Trial (Cytoreductive Nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Cytoreductive Nephrectomy
      • (no location specified)
      Jul 3, 2023

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pucotenlimab Combined With Lenvatinib
      • Guangzhou, Other (Non U.s.), China
        Sun Yat-sen University Cancer Center
      Nov 10, 2023

      Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • +3 more
      • Chengdu, Sichuan, China
        West China Hospital
      Apr 10, 2023